Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pradere

Showing results (221-230 of 412) with videos related to

Pageof 42
Sort By:
Translational Andrology and Urology|March 15, 2021
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
BJU International|October 13, 2024
VI-RADS followed by Photodynamic Transurethral Resection of Non-Muscle-Invasive Bladder Cancer vs White-Light Conventional and Second-resection: the 'CUT-less' Randomised Trial ProtocolFrancesco Del Giudice, Annarita Vestri, Danilo Alunni Fegatelli, et al.
Journal of Clinical Medicine|June 27, 2024
Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data StudyNikolaos Pyrgidis, Marco Moschini, Lazaros Tzelves, et al.
Cancers|September 9, 2022
Online Crowdfunding for Urologic Cancer CarePawel Rajwa, Philip Hopen, Jakub Wojnarowicz, et al.
European Urology Focus|February 11, 2023
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysisTatsushi Kawada, Takafumi Yanagisawa, Hadi Mostafaei, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter StudyVictor M Schuettfort, Benjamin Pradere, Hadi Mostafaei, et al.
World Journal of Urology|February 11, 2018
Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre studyJean-Baptiste Beauval, Benoit Peyronnet, Thibaut Benoit, et al.
Urologic Oncology|September 23, 2020
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D Andrea, et al.
Minerva Urology and Nephrology|March 26, 2021
Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
European Urology|October 1, 2024
FGFR Inhibition in Urothelial CarcinomaRoger Li, Joshua Linscott, James W F Catto, et al.
Pageof 42

Showing results (221-230 of 412) with videos related to

Sort By:
Pageof 42
Translational Andrology and Urology|March 15, 2021
Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
BJU International|October 13, 2024
VI-RADS followed by Photodynamic Transurethral Resection of Non-Muscle-Invasive Bladder Cancer vs White-Light Conventional and Second-resection: the 'CUT-less' Randomised Trial ProtocolFrancesco Del Giudice, Annarita Vestri, Danilo Alunni Fegatelli, et al.
Journal of Clinical Medicine|June 27, 2024
Perioperative Outcomes and Trends in Transurethral Resection of Bladder Tumors with Photodynamic Diagnosis: Results from the GeRmAn Nationwide Inpatient Data StudyNikolaos Pyrgidis, Marco Moschini, Lazaros Tzelves, et al.
Cancers|September 9, 2022
Online Crowdfunding for Urologic Cancer CarePawel Rajwa, Philip Hopen, Jakub Wojnarowicz, et al.
European Urology Focus|February 11, 2023
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysisTatsushi Kawada, Takafumi Yanagisawa, Hadi Mostafaei, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Benefit of Adjuvant Chemotherapy After Radical Cystectomy for Treatment of Urothelial Carcinoma of the Bladder in the Elderly -An International Multicenter StudyVictor M Schuettfort, Benjamin Pradere, Hadi Mostafaei, et al.
World Journal of Urology|February 11, 2018
Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre studyJean-Baptiste Beauval, Benoit Peyronnet, Thibaut Benoit, et al.
Urologic Oncology|September 23, 2020
Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D Andrea, et al.
Minerva Urology and Nephrology|March 26, 2021
Prognostic effect of preoperative systemic immune-inflammation index in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinomaEkaterina Laukhtina, Benjamin Pradere, David D'Andrea, et al.
European Urology|October 1, 2024
FGFR Inhibition in Urothelial CarcinomaRoger Li, Joshua Linscott, James W F Catto, et al.
Pageof 42